1:06wellnessNovember 30, 2022Drug's performance offers new hope in Alzheimer's battleNewly released findings on Lecanemab show it slowed the rate of cognitive decline by 27% in patients in the early stages of the disease.Up Next in wellnessFDA permits marketing of diagnostic test for Alzheimer's diseaseMay 5, 2022Digital creator shares video of her dog staying with her during a seizure March 26, 2024What is septic shock?January 31, 2024